Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV [clinicaltrials:NCT00011011]
Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV [clinicaltrials:NCT00011011]
Bio2RDF identifier
NCT00011011
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00011011
identifiers.org URI
actual enrollment [clinicaltrials_vocabulary:actual-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
Long-term control of HI ...... rol of HIV in these patients.
brief title [clinicaltrials_vocabulary:brief-title]
Vaccine (ALVAC-HIV vCP1452) Us ...... HIV Drugs in Patients With HIV
completion date [clinicaltrials_vocabulary:completion-date]
2006-10-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
The best hope for long- ...... t Infected T-Cell Clearance).
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2001-02-08T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
is section 801 [clinicaltrials_vocabulary:is-section-801]
keyword [clinicaltrials_vocabulary:keyword]
AIDS Vaccines
Anti-HIV Agents
CD4 Lymphocyte Count
Drug Administration Schedule
HIV Therapeutic Vaccine
RNA, Viral
Treatment Interruption
Viral Load
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2013-07-30T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00011011
official title [clinicaltrials_vocabulary:official-title]
A Randomized Phase I/II Pilot ...... Levels Less Than 50 Copies/ml
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
reference [clinicaltrials_vocabulary:reference]
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2001-02-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2013-07-01T00:00:00Z
identifier
clinicaltrials:NCT00011011
title
Vaccine (ALVAC-HIV vCP1452) Us ...... HIV Drugs in Patients With HIV
@en
type
label
Vaccine (ALVAC-HIV vCP1452) Us ...... V [clinicaltrials:NCT00011011]
@en